Predicting Richter's Transformation in Patients With CLL Receiving Ibrutinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib
Am. J. Hematol 2022 Oct 10;[EPub Ahead of Print], AS Kittai, Y Huang, KA Beckwith, SA Bhat, DA Bond, JC Byrd, D Goldstein, MR Grever, C Miller, KA Rogers, M Yano, JA WoyachFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.